Roderer Kathrin, Neuenschwander Martin, Codoni Giosiana, Sasso Severin, Gamper Marianne, Kast Peter
Laboratory of Organic Chemistry, ETH Zurich, CH-8093, Zurich, Switzerland.
PLoS One. 2014 Dec 31;9(12):e116234. doi: 10.1371/journal.pone.0116234. eCollection 2014.
The shikimate pathway enzyme chorismate mutase converts chorismate into prephenate, a precursor of Tyr and Phe. The intracellular chorismate mutase (MtCM) of Mycobacterium tuberculosis is poorly active on its own, but becomes >100-fold more efficient upon formation of a complex with the first enzyme of the shikimate pathway, 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase (MtDS). The crystal structure of the enzyme complex revealed involvement of C-terminal MtCM residues with the MtDS interface. Here we employed evolutionary strategies to probe the tolerance to substitution of the C-terminal MtCM residues from positions 84-90. Variants with randomized positions were subjected to stringent selection in vivo requiring productive interactions with MtDS for survival. Sequence patterns identified in active library members coincide with residue conservation in natural chorismate mutases of the AroQδ subclass to which MtCM belongs. An Arg-Gly dyad at positions 85 and 86, invariant in AroQδ sequences, was intolerant to mutation, whereas Leu88 and Gly89 exhibited a preference for small and hydrophobic residues in functional MtCM-MtDS complexes. In the absence of MtDS, selection under relaxed conditions identifies positions 84-86 as MtCM integrity determinants, suggesting that the more C-terminal residues function in the activation by MtDS. Several MtCM variants, purified using a novel plasmid-based T7 RNA polymerase gene expression system, showed that a diminished ability to physically interact with MtDS correlates with reduced activatability and feedback regulatory control by Tyr and Phe. Mapping critical protein-protein interaction sites by evolutionary strategies may pinpoint promising targets for drugs that interfere with the activity of protein complexes.
莽草酸途径中的酶分支酸变位酶将分支酸转化为预苯酸,后者是酪氨酸和苯丙氨酸的前体。结核分枝杆菌的细胞内分支酸变位酶(MtCM)自身活性很低,但与莽草酸途径的第一种酶3-脱氧-D-阿拉伯庚酮糖-7-磷酸合酶(MtDS)形成复合物后,活性提高100倍以上。该酶复合物的晶体结构显示,MtCM C端残基参与了与MtDS的界面相互作用。在此,我们采用进化策略来探究MtCM C端84 - 90位残基对取代的耐受性。对随机位点的变体在体内进行严格筛选,只有与MtDS进行有效相互作用才能存活。在活性文库成员中鉴定出的序列模式与MtCM所属的AroQδ亚类天然分支酸变位酶中的残基保守性一致。AroQδ序列中85和86位的精氨酸 - 甘氨酸二联体对突变不耐受,而在功能性MtCM - MtDS复合物中,Leu88和Gly89表现出对小的疏水残基的偏好。在没有MtDS的情况下,在宽松条件下进行筛选可确定84 - 86位为MtCM完整性的决定因素,这表明C端残基在MtDS介导的激活中发挥作用。使用基于新型质粒的T7 RNA聚合酶基因表达系统纯化的几种MtCM变体表明,与MtDS物理相互作用能力的降低与酪氨酸和苯丙氨酸介导的激活能力及反馈调节控制的降低相关。通过进化策略绘制关键的蛋白质 - 蛋白质相互作用位点,可能会确定干扰蛋白质复合物活性的有前景的药物靶点。